back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-11-17 09:33 Tx date 2025-11-13 |
$BNXT
BioNxt Solutions Inc. |
Rogers, Hugh Allison Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-20,880
-24,000 vol $0.87 each |
909,500 | |
| Filed 2025-11-17 09:33 Tx date 2025-11-13 |
$BNXT
BioNxt Solutions Inc. |
Rogers, Hugh Allison Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-21,859.50
-28,500 vol $0.77 each |
933,500 | |
| Filed 2025-11-17 09:32 Tx date 2025-11-13 |
$BNXT
BioNxt Solutions Inc. |
Rogers, Hugh Allison Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,710
-15,500 vol $0.82 each |
962,000 | |
| Filed 2025-10-15 13:32 Tx date 2025-10-10 |
$BNXT
BioNxt Solutions Inc. |
Rogers, Hugh Allison Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-20,880
-24,000 vol $0.87 each |
977,500 | |
| Filed 2025-08-25 16:16 Tx date 2025-08-22 |
$BNXT
BioNxt Solutions Inc. |
Rogers, Hugh Allison Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+290,000 vol |
1,001,500 | |
| Filed 2025-08-25 16:15 Tx date 2025-08-22 |
$BNXT
BioNxt Solutions Inc. |
Rogers, Hugh Allison Douglas
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-290,000 vol |
290,000 | |
| Filed 2025-07-16 18:16 Tx date 2022-12-16 |
$BNXT
BioNxt Solutions Inc. |
Rogers, Hugh Allison Douglas
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-286,000 vol |
300,000 | |
| Filed 2025-07-16 18:14 Tx date 2022-08-07 |
$BNXT
BioNxt Solutions Inc. |
Rogers, Hugh Allison Douglas
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-200,000 vol |
586,000 | |
| Filed 2025-07-16 18:13 Tx date 2022-12-16 |
$BNXT
BioNxt Solutions Inc. |
Rogers, Hugh Allison Douglas
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-650,000 vol |
||
| Filed 2025-06-02 09:19 Tx date 2025-01-31 |
$BNXT
BioNxt Solutions Inc. |
Rogers, Hugh Allison Douglas
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+580,000 vol |
580,000 | |
| Filed 2025-06-02 09:18 Tx date 2017-12-17 |
$BNXT
BioNxt Solutions Inc. |
Rogers, Hugh Allison Douglas
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-06-02 09:18 Tx date 2025-01-31 |
$BNXT
BioNxt Solutions Inc. |
Rogers, Hugh Allison Douglas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$500,000
+1,000,000 vol $0.50 each |
2,086,000 | |
| Filed 2025-05-27 16:11 Tx date 2025-05-26 |
$N/A
NEXCEL METALS CORP. |
Rogers, Hugh Allison Douglas
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,500,000 | ||
| Filed 2025-03-11 18:04 Tx date 2025-03-06 |
$TELO
Telo Genomics Corp. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$52,500
+350,000 vol $0.15 each |
650,000 | |
| Filed 2023-04-06 19:07 Tx date 2023-04-04 |
$BNXT
BioNxt Solutions Inc. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$240,000
+300,000 vol $0.80 each |
1,086,000 | |
| Filed 2022-03-21 15:44 Tx date 2022-03-14 |
$XPHY
XPhyto Therapeutics Corp. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-107,625
-102,500 vol $1.05 each |
347,500 | |
| Filed 2022-03-21 15:42 Tx date 2022-03-14 |
$XPHY
XPhyto Therapeutics Corp. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-76,500
-75,000 vol $1.02 each |
450,000 | |
| Filed 2022-03-18 15:30 Tx date 2022-03-16 |
$XPHY
XPhyto Therapeutics Corp. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$182,000
+364,000 vol $0.50 each |
889,000 | |
| Filed 2022-03-18 15:29 Tx date 2022-03-16 |
$XPHY
XPhyto Therapeutics Corp. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-182,000
-364,000 vol $0.50 each |
786,000 | |
| Filed 2021-12-08 12:37 Tx date 2021-11-29 |
$XPHY
XPhyto Therapeutics Corp. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$375,000
+300,000 vol $1.25 each |
1,150,000 |